Introduction: To evaluate the feasibility and safety of bilateral single-session ureteroscopy in the treatment of bilateral stones with different localizations. Materials and Methods: Between February 2001 and October 2006, a total of 1,296 patients underwent ureteroscopy with pneumatic lithotripsy. Of these, 38 patients (2.9%) had bilateral ureter stones. The stones were located in the lower, middle and upper ureter in 44 (57.9%), 21 (27.6%) and 11 (14.5%) of the cases, respectively. Fifty-one stones (67.1%) were less than 1 cm. Results: Of the 76 stones, 67 (88.1%) were fragmented in a single procedure. The stone clearance rate was 93.1% after the second session. According to the localization of the stones, the stone clearance rate after single endoscopic session was 72.7% for upper ureteral calculi, 80.9% for midureter and 95.4% for lower ureter stones. For patients with calculi less than 1 cm and greater than 1 cm, the initial stone-free rate after ureteroscopy was 94.1% (48 of 51) and 76% (19 of 25), respectively (p < 0.05). No major complication was observed. Conclusions: Bilateral single-session pneumatic lithotripsy can be performed safely and has high success rates with minimal morbidity and short hospital stay.

Keywords:
Bilateral stones, Ureterorenoscopy, Pneumatic lithotripsy
This content is only available via PDF.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.